Loading clinical trials...
Loading clinical trials...
Identifying Markers of Disease Subtypes and Disease Progression in the Syndrome of Essential Tremor - a Prospective Cohort Study
Conditions
Interventions
Clinical examination, blood draw, cerebral MRI, sonography, tremor analysis, OCT, olfactory mucosa swab.
Locations
1
Austria
Medical University of Graz
Graz, Austria, Austria
Start Date
April 4, 2024
Primary Completion Date
April 30, 2026
Completion Date
April 30, 2034
Last Updated
September 29, 2025
NCT07428447
NCT07417280
NCT04212780
NCT03984643
NCT01581580
NCT07056361
Lead Sponsor
Medical University of Graz
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions